Rani Therapeutics Holdings (RANI) Change in Receivables (2025)

Rani Therapeutics Holdings has reported Change in Receivables for 1 years, with the latest figure at $2.5 million in Q4 2025.

• On a quarterly basis, Change in Receivables changed N/A year-over-year to $2.5 million in Q4 2025; TTM through Jun 2026 was $2.5 million, a 677.1% increase from a year earlier, with the FY2025 full-year figure at $2.0 million, changed N/A from the prior year.
• Change in Receivables was $2.5 million for Q4 2025 at Rani Therapeutics Holdings, up from -$1.0 million in the prior quarter.
• The five-year high for Change in Receivables was $2.5 million in Q4 2025, with the low at -$1.0 million in Q2 2025.